Medication: Greater Patent Data Transparency for More Affordable Drugs
This act aims to increase transparency in drug patent information. Pharmaceutical companies will be required to share consistent data with both the patent office and the food and drug agency. This is intended to facilitate the faster introduction of more affordable generic drugs, potentially lowering healthcare costs for citizens.
Key points
Drug companies must disclose consistent patent information to both the patent office and the food and drug agency.
Failure to fully disclose data may prevent new drug approval or weaken a company's patent protection.
The goal is to streamline the market entry of generic and biosimilar drugs, potentially leading to lower medication prices for patients.
Expired
Citizen Poll